Flagship Harbor Advisors LLC Sells 241 Shares of SPDR S&P Biotech ETF $XBI

Flagship Harbor Advisors LLC lowered its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 1.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 17,415 shares of the exchange traded fund’s stock after selling 241 shares during the quarter. Flagship Harbor Advisors LLC’s holdings in SPDR S&P Biotech ETF were worth $1,444,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. DHJJ Financial Advisors Ltd. bought a new stake in SPDR S&P Biotech ETF in the second quarter valued at about $25,000. Garrison Bradford & Associates Inc. bought a new stake in SPDR S&P Biotech ETF during the first quarter worth about $39,000. Quaker Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 101.2% during the second quarter. Quaker Wealth Management LLC now owns 623 shares of the exchange traded fund’s stock worth $52,000 after buying an additional 53,536 shares during the last quarter. Compass Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 46.0% during the first quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock worth $51,000 after buying an additional 200 shares during the last quarter. Finally, Golden State Wealth Management LLC grew its stake in SPDR S&P Biotech ETF by 100.0% during the first quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock worth $52,000 after buying an additional 319 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $110.96 on Thursday. The firm has a market cap of $6.81 billion, a P/E ratio of 11.47 and a beta of 0.93. The firm has a 50 day simple moving average of $99.41 and a 200 day simple moving average of $88.76. SPDR S&P Biotech ETF has a fifty-two week low of $66.66 and a fifty-two week high of $112.61.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.